Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Helius Medical Technologies Inc (HSDT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 56,821
  • Shares Outstanding, K 23,383
  • Annual Sales, $ 480 K
  • Annual Income, $ -28,620 K
  • 60-Month Beta 0.38
  • Price/Sales 121.81
  • Price/Cash Flow N/A
  • Price/Book 5.91

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.22
  • Number of Estimates 1
  • High Estimate -0.22
  • Low Estimate -0.22
  • Prior Year -0.08
  • Growth Rate Est. (year over year) -175.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.77 +35.59%
on 04/11/19
6.92 -65.32%
on 03/26/19
-4.45 (-64.96%)
since 03/25/19
3-Month
1.77 +35.59%
on 04/11/19
7.85 -69.43%
on 02/19/19
-4.73 (-66.34%)
since 01/25/19
52-Week
1.77 +35.59%
on 04/11/19
13.20 -81.82%
on 06/18/18
-5.82 (-70.80%)
since 04/25/18

Most Recent Stories

More News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Helius Medical Technologies, Inc. - HSDT

Pomerantz LLP is investigating claims on behalf of investors of Helius Medical Technologies, Inc. ("Helius" or the "Company") (NASDAQ: HSDT). Such investors are advised to contact Robert S. Willoughby...

HSDT : 2.37 (-2.47%)
Global Cellulite Treatments Market Could Exceed $1.4 Billion by 2026

The global cellulite market and its largest segment, the non-invasive treatment sector, are both expected to grow at a healthy rate. A recent industry report on the entire cellulite market (from Transparency...

HSM.TO : 3.28 (-2.09%)
CTLT : 44.37 (-0.18%)
HSDT : 2.37 (-2.47%)
VRAY : 7.03 (+0.14%)
MDT : 86.61 (+1.13%)
SOLY : 12.09 (-1.95%)
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Helius Medical Technologies, Inc. Investors (HSDT)

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Helius Medical Technologies, Inc. ("Helius" or the "Company") (NASDAQ: HSDT) investors concerning the Company and its officers'...

HSDT : 2.37 (-2.47%)
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Helius Medical Technologies, Inc. Investors (HSDT)

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Helius Medical Technologies, Inc. ("Helius" or the "Company") (NASDAQ: HSDT) investors concerning the Company...

HSDT : 2.37 (-2.47%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Helius Medical Technologies, Inc. - HSDT

Pomerantz LLP is investigating claims on behalf of investors of Helius Medical Technologies, Inc. ("Helius" or the "Company") (NASDAQ: HSDT). Such investors are advised to contact Robert S. Willoughby...

HSDT : 2.37 (-2.47%)
INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Helius Medical Technologies, Inc.

The law firm of Kirby McInerney LLP is investigating potential claims against Helius Medical Technologies, Inc. ("Helius" or the "Company") (NASDAQ: HSDT). This investigation concerns...

HSDT : 2.37 (-2.47%)
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Helius Medical Technologies, Inc. Investors

Law Offices of Howard G. Smithannounces an investigation on behalf of Helius Medical Technologies, Inc. investors ("Helius" or the "Company") (NASDAQ:HSDT) concerning the Company and...

HSDT : 2.37 (-2.47%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Helius Medical Technologies, Inc. - HSDT

Pomerantz LLP is investigating claims on behalf of investors of Helius Medical Technologies, Inc. ("Helius" or the "Company") (NASDAQ: HSDT). Such investors are advised to contact Robert S. Willoughby...

HSDT : 2.37 (-2.47%)
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Helius Medical Technologies, Inc. Investors

Law Offices of Howard G. Smithannounces an investigation on behalf of Helius Medical Technologies, Inc. investors ("Helius" or the "Company") (NASDAQ:HSDT) concerning the Company and...

HSDT : 2.37 (-2.47%)
Helius Medical Technologies, Inc. Investigated by Block & Leviton LLP For Violations of Federal Securities Laws

Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Helius Medical Technologies, Inc. ("Helius" or the "Company") (NASDAQ: HSDT)...

HSDT : 2.37 (-2.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade HSDT with:

Business Summary

Helius Medical Technologies Inc. is a specialty medical device company. It is focused on the development and regulatory approval of its non-invasive neurostimulation device called PoNS. The Company is nearing clinical trials for balance disorders in TBI patients and for the treatment of MS. Helius Medical...

See More

Key Turning Points

2nd Resistance Point 2.60
1st Resistance Point 2.51
Last Price 2.37
1st Support Level 2.33
2nd Support Level 2.24

See More

52-Week High 13.20
Fibonacci 61.8% 8.83
Fibonacci 50% 7.48
Fibonacci 38.2% 6.14
Last Price 2.37
52-Week Low 1.77

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar